Detalhe da pesquisa
1.
Individual or combination treatments with lapatinib and paclitaxel cause potential bone loss and bone marrow adiposity in rats.
J Cell Biochem
; 120(3): 4180-4191, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30260048
2.
Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer.
Int J Cancer
; 142(2): 369-380, 2018 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28921512
3.
Matrix metalloproteinase expression is altered in the small and large intestine following fractionated radiation in vivo.
Support Care Cancer
; 26(11): 3873-3882, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29754212
4.
Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.
Int J Cancer
; 140(12): 2820-2829, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28316082
5.
Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model.
Breast Cancer Res Treat
; 165(1): 41-51, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550626
6.
Fractionated abdominal irradiation induces intestinal microvascular changes in an in vivo model of radiotherapy-induced gut toxicity.
Support Care Cancer
; 25(6): 1973-1983, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28175996
7.
Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats.
J Bone Miner Metab
; 34(3): 277-90, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26056019
8.
Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.
Curr Oncol Rep
; 17(11): 50, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26384312
9.
Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis.
J Oral Pathol Med
; 44(6): 459-67, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25213123
10.
Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy--a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines.
Support Care Cancer
; 23(1): 273-82, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25115892
11.
Rationale and design of the Pan Australasian chemotherapy-induced emesis burden of illness study.
Support Care Cancer
; 23(1): 253-61, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25115893
12.
Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice.
Support Care Cancer
; 23(1): 293-300, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25142702
13.
Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries.
Support Care Cancer
; 23(1): 263-72, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25120009
14.
Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice--a longitudinal analysis.
Support Care Cancer
; 23(1): 283-91, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25112561
15.
DOES ONE SIZE FIT ALL? COST UTILITY ANALYSES OF ALTERNATIVE MAMMOGRAPHIC FOLLOW-UP SCHEDULES, BY RISK OF RECURRENCE.
Int J Technol Assess Health Care
; 31(5): 281-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26654334
16.
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Cancer
; 120(10): 1453-61, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615748
17.
Predictors of acute adverse events from rapid rituximab infusion.
Support Care Cancer
; 21(8): 2315-20, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23525938
18.
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.
Support Care Cancer
; 21(1): 313-26, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23142924
19.
Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases.
Support Care Cancer
; 21(7): 1843-52, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23397098
20.
Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy.
Cancer Chemother Pharmacol
; 91(6): 507-521, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162533